NRX Pharmaceuticals Inc Annual Shareholders Meeting Transcript
Good morning, ladies and gentlemen, and welcome to the Annual Meeting of Stockholders of NRx Pharmaceuticals, Inc. I'm Stephen Willard, Chief Executive Officer of NRx and I'm very happy to be with you today. Thank you for joining us. I will be assisted in today's meeting by our Chief Financial Officer, Richard Narita, and by Dr. Jonathan Javitt, the founder of our company we will begin today with the formal part of the program during which we will ask the shareholders to one telephony tenant request as a Class two members of the company's Board of Directors to approve a proposed amendment to the company's 2021 Omnibus Incentive Plan to increase the maximum number of shares of common stock available for issuance under the plan three, ratify the selection of Solberg & Company PA as the company's independent auditors for the fiscal year ended December 31, 2023, four, approve on an advisory basis, the compensation of our named executive officers as set forth in the company's proxy statement and five approve on an advisory basis, the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
